IL112043A - Benzothiophene derivatives for use in inhibiting imperfect tissue repair - Google Patents
Benzothiophene derivatives for use in inhibiting imperfect tissue repairInfo
- Publication number
- IL112043A IL112043A IL11204394A IL11204394A IL112043A IL 112043 A IL112043 A IL 112043A IL 11204394 A IL11204394 A IL 11204394A IL 11204394 A IL11204394 A IL 11204394A IL 112043 A IL112043 A IL 112043A
- Authority
- IL
- Israel
- Prior art keywords
- tissue repair
- benzothiophene derivatives
- inhibiting
- imperfect tissue
- inhibiting imperfect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/171,150 US5574047A (en) | 1993-12-21 | 1993-12-21 | Methods of inhibiting imperfect tissue repair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL112043A0 IL112043A0 (en) | 1995-03-15 |
| IL112043A true IL112043A (en) | 2000-02-29 |
Family
ID=22622741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11204394A IL112043A (en) | 1993-12-21 | 1994-12-19 | Benzothiophene derivatives for use in inhibiting imperfect tissue repair |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5574047A (ko) |
| EP (1) | EP0664122A1 (ko) |
| JP (1) | JPH07215862A (ko) |
| KR (1) | KR950016740A (ko) |
| CN (1) | CN1051921C (ko) |
| AU (1) | AU690596B2 (ko) |
| CA (1) | CA2138454A1 (ko) |
| CZ (1) | CZ287766B6 (ko) |
| HU (1) | HUT71343A (ko) |
| IL (1) | IL112043A (ko) |
| NO (1) | NO313487B1 (ko) |
| NZ (1) | NZ270180A (ko) |
| PH (1) | PH31324A (ko) |
| RU (1) | RU2133121C1 (ko) |
| TW (1) | TW321600B (ko) |
| UA (1) | UA37212C2 (ko) |
| ZA (1) | ZA9410089B (ko) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| US5492927A (en) * | 1993-12-21 | 1996-02-20 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists to treat allergy |
| US5496828A (en) * | 1994-08-22 | 1996-03-05 | Eli Lilly And Company | Methods of inhibiting ulcerative mucositis |
| US5545641A (en) * | 1994-10-20 | 1996-08-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of bradykinin |
| US6562862B1 (en) | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
| AU708374B2 (en) * | 1995-02-06 | 1999-08-05 | Eli Lilly And Company | Methods of inhibiting effects of IL-6 |
| US5484808A (en) * | 1995-02-09 | 1996-01-16 | Eli Lilly And Company | Methods of inhibiting cell-cell adhesion |
| IL125523A0 (en) * | 1996-01-29 | 1999-03-12 | Lilly Co Eli | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| US5670523A (en) * | 1996-01-29 | 1997-09-23 | Eli Lilly And Company | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| ID15917A (id) * | 1996-01-29 | 1997-08-21 | Lilly Co Eli | Metode untuk menghambat tumor usus besar |
| US6063575A (en) * | 1997-03-21 | 2000-05-16 | University Of Maryland, At Baltimore | Assay for measuring the activity and fidelity of DNA replication and kit therefor |
| WO1998046588A2 (en) | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| JP2001518453A (ja) * | 1997-09-29 | 2001-10-16 | ユニバーシティ オブ メリーランド， ボルチモア | 悪性腫瘍の生体マーカーとしての改変されたｄｎａシンセソーム成分 |
| WO1999016469A1 (en) * | 1997-09-29 | 1999-04-08 | University Of Maryland, Baltimore | Altered dna synthesome components as biomarkers for malignancy |
| US6093543A (en) * | 1998-04-11 | 2000-07-25 | University Of Maryland, Baltimore | Method for detecting the presence of malignant cells using a multi-protein DNA replication complex |
| HUP0200871A3 (en) | 1999-05-04 | 2004-04-28 | Strakan Int Ltd | Androgen glycosides and androgenic activity thereof |
| WO2002060972A2 (en) * | 2001-01-29 | 2002-08-08 | Ndsu Research Foundation | Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof |
| US7294471B2 (en) * | 2002-02-27 | 2007-11-13 | Cskeys, Llc | Method for purifying cancer-specific proliferating cell nuclear antigen |
| JP4212036B2 (ja) * | 2003-06-19 | 2009-01-21 | ローム株式会社 | 定電圧発生器 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| EP0651637B1 (en) * | 1992-07-20 | 2006-10-04 | Massachusetts Institute Of Technology | Control of wound scar production with calmodulin inhibitors or protein kinase c inhibitors |
-
1993
- 1993-12-21 US US08/171,150 patent/US5574047A/en not_active Expired - Fee Related
-
1994
- 1994-12-19 HU HU9403674A patent/HUT71343A/hu unknown
- 1994-12-19 CZ CZ19943223A patent/CZ287766B6/cs not_active IP Right Cessation
- 1994-12-19 RU RU94044490/14A patent/RU2133121C1/ru not_active IP Right Cessation
- 1994-12-19 UA UA94129198A patent/UA37212C2/uk unknown
- 1994-12-19 KR KR1019940034931A patent/KR950016740A/ko not_active Application Discontinuation
- 1994-12-19 CA CA002138454A patent/CA2138454A1/en not_active Abandoned
- 1994-12-19 JP JP6314603A patent/JPH07215862A/ja active Pending
- 1994-12-19 AU AU81557/94A patent/AU690596B2/en not_active Ceased
- 1994-12-19 TW TW083111847A patent/TW321600B/zh active
- 1994-12-19 NZ NZ270180A patent/NZ270180A/en unknown
- 1994-12-19 EP EP94309463A patent/EP0664122A1/en not_active Withdrawn
- 1994-12-19 PH PH49575A patent/PH31324A/en unknown
- 1994-12-19 IL IL11204394A patent/IL112043A/xx not_active IP Right Cessation
- 1994-12-19 CN CN94119271A patent/CN1051921C/zh not_active Expired - Fee Related
- 1994-12-19 NO NO19944922A patent/NO313487B1/no unknown
- 1994-12-19 ZA ZA9410089A patent/ZA9410089B/xx unknown
-
1995
- 1995-03-15 US US08/404,855 patent/US5686467A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO944922D0 (no) | 1994-12-19 |
| HU9403674D0 (en) | 1995-02-28 |
| NO313487B1 (no) | 2002-10-14 |
| RU94044490A (ru) | 1996-10-20 |
| US5686467A (en) | 1997-11-11 |
| AU8155794A (en) | 1995-06-29 |
| CA2138454A1 (en) | 1995-06-22 |
| CZ322394A3 (en) | 1995-09-13 |
| UA37212C2 (uk) | 2001-05-15 |
| CZ287766B6 (en) | 2001-01-17 |
| CN1051921C (zh) | 2000-05-03 |
| AU690596B2 (en) | 1998-04-30 |
| TW321600B (ko) | 1997-12-01 |
| RU2133121C1 (ru) | 1999-07-20 |
| NZ270180A (en) | 1997-07-27 |
| IL112043A0 (en) | 1995-03-15 |
| PH31324A (en) | 1998-07-06 |
| US5574047A (en) | 1996-11-12 |
| CN1109330A (zh) | 1995-10-04 |
| JPH07215862A (ja) | 1995-08-15 |
| KR950016740A (ko) | 1995-07-20 |
| HUT71343A (en) | 1995-11-28 |
| ZA9410089B (en) | 1996-06-19 |
| EP0664122A1 (en) | 1995-07-26 |
| NO944922L (no) | 1995-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112043A (en) | Benzothiophene derivatives for use in inhibiting imperfect tissue repair | |
| US5571100B1 (en) | Electrosurgical apparatus | |
| IL115479A0 (en) | Composition for ophthalmic use | |
| GB9322464D0 (en) | Electrosurgical apparatus | |
| EP0746319A4 (en) | ACYCLOVIR DERIVATIVES FOR TOPICAL USE | |
| HU9402963D0 (en) | Methods for inhibiting bone loss | |
| IL112031A (en) | 2-Phenyl-3-Aroylbenzothiophene derivatives for use in inhibiting autoimmune disorders | |
| ZA96851B (en) | Proline derivatives | |
| IL115020A0 (en) | Methods for inhibiting neuronal damage | |
| LTIP1970A (en) | Composition for ophthalmic use | |
| IL122560A0 (en) | Use for pyrrole derivatives | |
| HU9402534D0 (en) | New naphtoxazine derivatives | |
| GB9319848D0 (en) | Tissue repair | |
| GB2291375B (en) | Bollard refurbishment | |
| LTIP1969A (en) | Composition for ophthalmic use | |
| GB9418240D0 (en) | Tissue repair | |
| GB9417996D0 (en) | Tissue repair | |
| PL57773Y1 (en) | Cryapplicator for use in cryosurgery | |
| GB9320634D0 (en) | Pyrrolidine derivatives | |
| ZA958488B (en) | Composition for ophthalmic use | |
| GB9600904D0 (en) | Proline derivatives | |
| GB9414135D0 (en) | 6-substituted-4-azahydro-benzo-(f)quinolin-3-one derivatives as 5a-reductase inhibitors | |
| GB9618891D0 (en) | Tissue repair | |
| IL145865A0 (en) | Benzothiophene derivatives | |
| GB9518464D0 (en) | Tissue repair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |